Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

A surge in Inventiva shares, up about 50% in the first few weeks of 2026, highlights investors' appetite for ​betting on the ...

Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million in its Nasdaq debut, joining a series of biotechs chipping away at 2025’s iced-over IPO market. | Immunology biotech ...

But deciding if it's a good buy takes a little more looking.

Shares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full analysis here.

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...

DELRAY BEACH, Fla., Oct. 31, 2025 /PRNewswire/ -- According to MarketsandMarkets(TM), The agriculture biotechnology market is projected to grow from USD 92.19 billion in 2025 to USD 144.25 billion by ...

Stay updated on biotech layoffs in 2026! Each week, we track and analyze industry layoffs, their causes, and their impact.

Shares Biotechnology ETF earns a reiterated hold rating as it consolidates near all-time highs with balanced risk/reward.

As highlighted by Towards Packaging research, the global pouch materials for pharmaceutical market, valued at USD 10.59 ...